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Abstract 
BACKGROUND AND AIM: Oral squamous cell carcinoma (OSCC) is a rapidly progressive disease and despite the 
progress in the treatment of cancer, remains a life-threatening illness with a poor prognosis. Diagnostic techniques of 
the oral cavity are not painful, non-invasive, simple and inexpensive methods. Clinical decision support systems 
(CDSSs) are the most important diagnostic technologies used to help health professionals to analyze patients’ data and 
make decisions. This paper, by studying CDSS applications in the process of providing care for the cancer patients, has 
looked into the CDSS potentials in OSCC diagnosis. 
METHODS: We retrieved relevant articles indexed in MEDLINE/PubMed database using high-quality keywords. First, 
the title and then the abstract of the related articles were reviewed in the step of screening. Only research articles which 
had designed clinical decision support system in different stages of providing care for the cancer patient were retained 
in this study according to the input criteria. 
RESULTS: Various studies have been conducted about the important roles of CDSS in health processes related to 
different types of cancer. According to the aim of studies, we categorized them into several groups including treatment, 
diagnosis, risk assessment, screening, and survival estimation. 
CONCLUSION: Successful experiences in the field of CDSS applications in different types of cancer have indicated that 
machine learning methods have a high potential to manage the data and diagnostic improvement in OSCC intelligently 
and accurately. 
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ral cavity cancer refers to all 
malignancies of the lips, mouth and 
neck, among which oral squamous 
cell carcinoma (OSCC) is the most 
common one.1,2 Etiology and biological 
behavior studies of OSCC have suggested 
that this carcinoma develops a more 
aggressive behavior with poor prognosis.3,4  
In response to the need for early detection 
of OSCC, several diagnostic techniques have 
been developed over the years, mostly 
including vital staining, light-based detection 
systems, histological techniques, cytological 
techniques, molecular analyses and imaging 
O 
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techniques.5,6 One of the most considerable 
improvements in the healthcare area is a 
trend to the non-invasive interventions in the 
diagnosis and treatment of diseases.  
In recent years, numerous studies have been 
conducted to identify and assess the diagnostic 
biomarkers for OSCC. Identification of reliable 
biological tumor markers showed high 
sensitivity, efficiency and specificity for oral 
cancer and can be an additional tool for 
diagnosis, prognosis and treatment monitoring 
of patients with cancer.7 
Also, use of the computers to assist health 
professionals in their activities has become 
popular in recent decades. The first efforts 
focused on the development of diagnostic 
systems. Clinical decision support systems 
(CDSSs) are the most important diagnostic 
technologies used to help health 
professionals to analyze patient data and 
make decisions.8 
The advent of high information 
technology and dental devices has produced 
vast amounts of data. Moreover, the use of 
data mining algorithms and artificial 
intelligence techniques in dental informatics 
has a great potential to manage new big data. 
However, few efforts have been made to 
apply these techniques and relatively little 
research has been conducted to retrieve 
meaningful information from dental data. 
Some studies have used k-means clustering 
methods to establish normative data on tooth 
size9 in order to categorize the patients with 
facial asymmetry into the groups with 
different characteristics.10 Detection of oral 
cancer by applying k-means clustering and 
principal component analyses was carried 
out by the spectra obtained from 
autofluorescence spectroscopy.11 
The use of expert systems also has been 
associated with successful experiences in 
dentistry. For example, an expert system has 
helped decision making and treatment of the 
most common periodontal conditions.12 
Another expert system has used neural 
artificial intelligence to test the accuracy of 
periodontal disease risk assessment.13 
Moreover, another expert system has 
determined the diagnosis, disease severity 
and the treatment methods in periodontal 
diseases based on the patient clinical data 
and radiographic findings.14  
The appearance of CDSS in dentistry has 
addressed the several major areas of dental 
practice. Different types of knowledge 
representation and different modalities have 
been used in its development. A prediction 
system was developed in orthodontics where 
extraction/non-extraction decisions are very 
important. This system has been successfully 
optimized to obtain the concise 
representation of the expertise knowledge 
elements with prediction accuracy.15 A triage 
tool was designed and successfully evaluated 
to determine the patient’s examination 
waiting time by describing their clinical 
symptoms in the dental care unit.16 A study 
was conducted with the objective of 
developing a decision support system for 
predicting the degree of color change after in-
office tooth whitening by using colorimetric 
values. The patients’ post-treatment color 
was largely close to the system prediction.17 
A comprehensive review of the literature 
on decision support applications in dentistry, 
grouped these systems into seven subareas of 
dentistry: dental emergencies and trauma, 
orofacial pain, oral medicine, oral radiology, 
orthodontics, pulpal diagnosis, and 
restorative dentistry.18 
CDSSs have a great potential for providing 
the opportunities to improve patient care in 
various fields of oral medicine especially in 
oral cancer, through managing a large 
amount of data intelligently.  
The present study aims to review the 
literature on the CDSS applications in cancer 
with special attention to oral cancer. 
Therefore, key questions in this study 
include: 1- What are the CDSS applications in 
the process of providing care for the cancer 
patient? 2- What applications have been used 
in oral cancer? 3- Have been CDSS 
applications used in OSCC? 
A description with details of the CDSS 
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applications in health processes related to 
different types of cancer provides an 
appropriate model for highlighting their 
potentials for diagnostic accuracy 
improvement in OSCC. 
Methods 
This study was a systematic review to identify 
articles published in PubMed and focusing on 
CDSS applications in cancer. We searched the 
database in September 2016 with the following 
strategy: (("Neoplasms"[MeSH]) AND 
"Decision Support Systems, Clinical"[MeSH] 
AND Humans [MeSH] AND English [lang]) 
Filters: Humans; English. 
After the identification step, we screened 
the titles and abstracts of the related articles 
according to the inclusion/exclusion criteria. 
Inclusion criteria included only original 
articles, designed and used clinical decision 
support system in different stages of 
providing care for the cancer patients. No 
date restriction was applied to the search. 
Due to the limitations of searching database 
alone and in order to avoid missing related 
articles, we focused on article citations and 
before-and-after studies. Studies were 
excluded where they were not relevant to the 
key questions. The search was limited to 
journal articles written in the English 
language. Letters, reviews and conference 
proceedings also were excluded. 
After screening the titles and abstracts of 
potential articles, remaining studies were 
subjected to the screening of their main 
content, which in turn, their full-texts were 
reviewed. Figure 1 shows the flow of the 
article selection procedure. 
Data extraction and validity assessment 
were performed in two steps. First, a 
checklist was developed as an assessment 
tool with the aim of answering the key 
questions. Intended variables included 
references, objective, cancer type and result. 
Details from each article were extracted by 
two independent reviewers. In the second 
step and in order to have a systemic 
investigation, the variables collected in the 
data extraction form were classified into 
separate groups. 
Results 
A total of 414 potentially relevant titles, 
abstracts, and articles were found in 
MEDLINE/PubMed search. Non-pertinent 
papers were excluded according to inclusion 
and exclusion criteria after screening the titles 
and abstracts. We reviewed the full-texts of 
the remaining 82 articles. Finally, 17 articles 
met the inclusion criteria and considered as 
the final samples. Table 1 indicates the 
variable extracted from articles. 
 
 
Figure 1. Article selection procedure 
Total number of papers found from search strategy (n = 433)  
Filters activated: Humans, English (n = 414) 
Excluded after screening title and abstract  
(n = 332) 
Full text assessment – potentially relevant items (n = 89) 
Excluded articles: Did not meet at least one 
inclusion criteria (n = 74) 
Articles identified from before-and-after 
studies (n = 4) 
Articles met review inclusion criteria (n = 17) 
Articles going forward to data extraction (n = 13) 
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Table 1. Characteristics of included studies 
Reference Objective Cancer type Result 
Abernethy 
et al.
19
 
Educates clinical decision makers and 
healthcare professionals about the burden of 
cancer pain in their individual populations 
ALL Leads to improved pain control with modest 
increases in resource use 
Finlayson 
et al.
20
 
Providing an analytical engine and user 
interface that enables physicians to gain 
clinical insights by rapidly identifying and 
analyzing cohorts of patients similar to their 
own 
Melanoma The MRLU is an important component in 
building an RLS for data-driven precision 
medicine in melanoma treatment that could be 
generalized to other clinical disorders 
Mi et al.
21
 To select predictive features from clinical 
and PET-based features, in order to provide 
doctors with informative factors so as to 
anticipate the outcome of the patient 
treatment 
ALL Addition of prior knowledge improves the 
robustness and accelerates the convergence 
Cakir and 
Demirel
22
 
To help to oncology doctor for the 
suggestion of application of the treatment 
methods about breast cancer patients 
Breast 
cancer 
Data mining approach can be a useful tool for 
medical applications particularly at the 
treatment decision step 
Bury  
et al.
23
 
To assist with dosage adjustments during 
maintenance therapy for childhood ALL 
Lymphobla
stic 
Leukaemia 
Improvement in time taken to manage each 
case; accuracy of dosage calculations 
Gerbert  
et al.
24
 
To determine whether decision support 
software can help primary care physicians 
proficiently triage lesions suggestive of basal 
cell and squamous cell carcinoma 
Skin cancer Use of decision support software could 
improve primary care physicians' triage 
decisions for lesions suggestive of non-
melanoma skin cancer, and potentially reduce 
morbidity and health care costs 
Emery  
et al.
25
 
To evaluate the effect of an assessment 
strategy using the computer decision support 
system (the GRAIDS software), on the 
management of familial cancer risk 
Familial 
breast or 
colorectal 
cancer 
Improved practitioner confidence and had no 
adverse psychological effects in patients 
Ozanne  
et al.
26
 
Provides automated risk assessment and 
personalized decision support designed for 
collaborative use between patients and 
clinicians 
Breast 
cancer 
The ability to integrate risk assessment and 
decision support in real time will allow for 
informed, value-driven, and patient-centered 
breast cancer prevention decisions 
Javan 
Amoli  
et al.
27
 
Electronic risk assessment system as an 
appropriate tool for the prevention of cancer 
ALL Electronic pathways have been applied for 
clinical and genetic decision support, 
workflow management, update 
recommendation and resource estimates 
Shelton  
et al.
28
 
Implemented guidelines seeking to reduce 
PSA-based screening for prostate cancer in 
men aged 75 years and older 
Prostate 
cancer 
With this simple intervention, evidence-based 
guidelines were brought to bear at the point of 
care, precisely for the patients and providers 
for whom they were most helpful, resulting in 
more appropriate use of medical resources 
Hills  
et al.
29
 
Improving guideline-consistent cervical 
cancer screening practices in an urban safety 
net clinic 
Cervical 
cancer 
Patients screened according to guidelines 
nearly doubled while the number of 
underscreened patients was reduced by nearly 
half. Similarly, there was a threefold decrease 
in patients screened more frequently than 
recommended 
Maserat  
et al.
30
 
To detail engineering of information 
requirements and workflow design of CDSS 
for a colorectal cancer screening program 
Colorectal 
cancer 
A CDSS facilitates complex decision making 
for screening and has key roles in designing 
optimal interactions between colonoscopy, 
pathology and laboratory departments 
Lundin  
et al.
31
 
To evaluate the accuracy of an Internet-
based method for survival estimation in 
breast cancer 
Breast 
cancer 
A web-based case-match system can generate 
survival curves for user-defined prognostic 
factor combinations and identify patients with 
a varying risk for breast cancer recurrence 
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Table 1. Characteristics of included studies (continue) 
Reference Objective 
Cancer 
type 
Result 
Sidiropoul
os et al.
32
 
Supporting rare cancers decision making 
operates on a GPU and adjusting its design 
in real-time based on user-defined clinical 
questions in contrast to standard CPU 
implementations 
Brain 
cancer 
Enables real-time, optimal design of a CDSS 
for any user-defined clinical question for 
improving diagnostic assessments, prognostic 
relevance and concordance rates for rare 
cancers in clinical practice 
Exarchos 
et al.
33
 
To identify the factors that dictate OSCC 
progression and subsequently predict 
potential relapses (local or metastatic) of the 
disease 
Oral 
squamous 
cell 
carcinoma 
The discrimination potential of each source of 
data is initially explored separately, and 
afterward, the individual predictions are 
combined to yield a consensus decision 
achieving complete discrimination between 
patients with and without a disease relapse 
Nguyen  
et al.
34
 
To classify automatically lung TNM cancer 
stages from free-text pathology reports using 
symbolic rule-based classification 
Lung tumor It was verified that the symbolic rule-based 
approach using SNOMED CT can be used for 
the extraction of key lung cancer 
characteristics from free-text reports 
Nguyen  
et al.
35
 
Development of a Web-enabled relational 
database integrated with decision-making 
tools for teaching flow cytometric diagnosis 
of hematologic neoplasms 
Hematologi
c neoplasm 
This database shows significant improvement 
in diagnostic accuracy over our previous 
database prototype 
ALL: Acute lymphoblastic leukemia; MRLU: Melanoma rapid learning utility; RLS: Rapid learning system; PET: Positron emission 
tomography; PSA: Prostate-specific antigen; CDSSs: Clinical decision support systems; GPU: Graphics Processing Unit;  
CPU: Central processing unit; OSCC: Oral squamous cell carcinoma; TNM: Tumor-node-metastasis; SNOMED CT: Systematized 
nomenclature of medicine-clinical term 
 
In order to answer the key questions, we 
categorized the articles according to CDSS 
applications in the different stages of 
providing care for the cancer patients, 
including diagnosis, treatment, risk 
assessment, screening and survival estimation. 
CDSSs play an important role in different 
stages of cancer diagnosis and treatment. For 
example, some of these include a challenging 
decision making on chemotherapy protocols 
for a patient,36 supported the nurses' 
decision-making process about patients' 
needs and preparation of individual care 
plans.37 Another example of CDSS 
application is to help with the diagnosis 
within a gastroenterology room during real 
endoscopy examinations with human-
computer interaction (HCI) support 
methodologies in order to identify interaction 
opportunities,38 and precise selection of 
meningioma brain histopathological image 
classification.39 Also, it is used as a practical 
tool to improve the selection of protocols for 
monitoring, diagnosing, and treating cervical 
cancer in women and the patient-specific 
follow-up decision making for them.40 Some 
decision support systems have examined 
drug interactions of various diseases and 
may lead to undesirable and sometimes  
life-threatening reactions.41  
Furthermore, cancer screening programs 
have been run in different countries as a 
primary preventive measures in order to 
reduce damage and focus on the high-risk 
groups of cancer .7 In the screening process 
and to manage the cases with a positive test, 
especially for the patients at risk of 
developing cancer, presenting the report of 
the follow-up referral with the aim of 
providing therapeutic suggestions can be 
very effective. CDSSs have an important role 
in this context and upgrade the quality of the 
screening programs significantly. Moreover, 
the time saving of 1 minute and 39 seconds 
per patient consultation for providers has 
been calculated.42  
Few studies have examined the 
application of machine learning methods in 
OSCC. Only a multiparametric decision 
support system formulated for the prediction 
of OSCC reoccurrence. In this system, 
collected different type of data have included 
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clinical data, imaging and gene expression 
data in order to identify the factors that have 
potential involvement in OSCC progression 
and subsequently predict the possibility of a 
recurrence of the disease.43 Table 2 shows 
some of the different applications of CDSS in 
the stages of cancer. 
Discussion 
The advent of information technology in the 
field of medicine, and in particular the 
application of artificial intelligence, has led to 
significant progress in the data management 
especially in chronic diseases such as cancer. 
Discovering the patterns and relationships 
between them from the multiple and complex 
data sets have facilitated the effective 
prediction of future outcomes of cancer.44 In 
recent years, many studies have used 
molecular, clinical or population-based data 
to predict cancer susceptibility,45 recurrence43 
and survival.46,47 
Due to the nature of medical data, the 
success of any intelligent system largely 
depends on the input data optimality; 
therefore, using data mining approaches are 
essential in order to reduce the data dimension, 
optimal choice and Increase in accuracy.48  
Understanding of tumorigenesis can have a 
positive effect on the diagnosis and treatment 
process and also designing the more effective 
CDSSs. Different studies indicated that the 
following stages are required for cancer to 
form: 1- Acquisition of autonomous 
proliferative signaling, 2- Inhibition of growth 
inhibitory signals, 3- Evasion of programmed 
cell death, 4- Immortalization, 5- Acquisition of 
a nutrient blood supply (angiogenesis) and 6- 
Acquisition of the ability to invade tissue.44,49,50 
Although significant progress has been 
made in the treatment of cancer, survival rate 
remains unchanged and oral cancer remains a 
life-threatening illness with a poor prognosis.51  
OSCC is a rapidly progressive disease, 
although it can be a slower process by using 
several mechanisms, including defective 
antigen presentation, interference with 
tumor-T cell interaction and production of 
immunosuppressive factors.52  
Various studies have been conducted 
about the potentials and limitations of 
microarrays for the prediction of OSCC 
outcome, based on gene expression 
signatures.53,54 The bioinformatics method 
that can be used to distinguish OSCC and 
normal tissues is gene ontology (GO). GO 
analysis was used to investigate the critical 
genes in the progression of OSCC and 
protein-protein interaction (PPI) networks. 
Moreover, pathway enrichment analysis was 
performed to estimate the significant 
pathways.55 Studies that examine the impact 
of proteins on development and metastasis of 
OSCC through regulation of transcriptional 
responses, differentiation, angiogenesis, 
proliferation, and apoptotic programs can 
help researchers identify crucial targets for 
the prevention and treatment of OSCC.56 
The importance of early diagnosis, the 
prognosis of cancer type, classifying cancer 
patients into high or low-risk groups, also an 
improvement in screening uptake by a 
combination of risk factors including genetic, 
environmental and behavioral risk factors in 
primary care led to an interest in the use of 
information technology and artificial 
intelligence in this area.57 
Various surveys on the system 
development process have indicated the 
significant evolutions toward an effective 
improvement with regards to the patient, 
attention to organizational and economic 
issues and use of standard models for 
knowledge representation.58 Dentists positive 
attitudes at the outset of a system change can 
help organizational administrators with the 
adoption of evidence-based dentistry tools 
such as a CDSS system.59 
Efficiency and usability in CDSSs have a 
significant impact on users’ adoption,60 but 
designing a system with a multitude of 
warnings and suggestions and alarms is 
misleading and ambiguous.61 Therefore, 
special attention has to be paid to these 
points to design a convenient and functional 
system. Obviously, artificial intelligence 
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analysis of health data and clinical decision 
support system must be employed along 
with clinicians.62,63 Improving the capabilities 
of the CDSS and presenting it as an 
intelligent web service and providing access 
to dentists, as well as medical researchers, is 
an effective step in managing new and 
tracking past patients. 
Conclusion 
With the advent of information technologies 
in the field of medicine, especially computer-
based decision aids with embedded 
algorithms, there have been significant 
developments in the diagnosis and treatment 
of diseases.  
Clinical decision support system can have 
an effective role in classifying the patients 
with OSCC into the higher/lower risk of 
reoccurrence groups and determine the 
optimal treatment protocols in a cost-effective 
manner at the point of caregiver. 
Furthermore, the significant performance of 
the CDSS in improving the accuracy of early 
detection can play a vital role in reducing 
invasive treatments. 
The trend of diagnostic techniques of the 
oral cavity towards non-invasive methods 
and identification of reliable biological tumor 
markers for OSCC produces a large amount 
of data. CDSS can manage data intelligently 
and improve in diagnostic accuracy 
Obviously, several studies can be 
programmed on the application of the CDSS 
in susceptibility and survivability prediction 
in OSCC patient. 
Conflict of Interests 
Authors have no conflict of interest. 
Acknowledgments 
We would like to thank the library staffs of 
Tehran University of Medical Sciences, Iran, 
for their sincere cooperation and contribution 
to get results via searching the articles.  
 
References 
1. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade--an 
update (2000-2012). Asian Pac J Cancer Prev 2013; 14(10): 5567-77. 
2. Sahebjamee M, Mansourian A, Etemad-Moghadam S, Shamshiri AR, Derakhshan S. Conventional versus 
Papanicolaou-stained cytobrush biopsy in the diagnosis of oral squamous cell carcinoma. Oral Health Dent Manag 
2014; 13(3): 619-22. 
3. Durr ML, van Zante A, Li D, Kezirian EJ, Wang SJ. Oral tongue squamous cell carcinoma in never-smokers: Analysis 
of clinicopathologic characteristics and survival. Otolaryngol Head Neck Surg 2013; 149(1): 89-96. 
4. Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, Bahar G, et al. Squamous cell carcinoma of the oral tongue in 
patients younger than 30 years: Clinicopathologic features and outcome. Clin Otolaryngol 2010; 35(4): 307-12. 
5. Carreras-Torras C, Gay-Escoda C. Techniques for early diagnosis of oral squamous cell carcinoma: Systematic review. 
Med Oral Patol Oral Cir Bucal 2015; 20(3): e305-e315. 
6. Cheng YS, Rees T, Wright J. Updates regarding diagnostic adjuncts for oral squamous cell carcinoma. Tex Dent J 
2015; 132(8): 538-49. 
7. Tian X, Chen Z, Shi S, Wang X, Wang W, Li N, et al. Clinical diagnostic implications of body fluid MiRNA in oral 
squamous cell carcinoma: A meta-analysis. Medicine (Baltimore) 2015; 94(37): e1324. 
8. Mendonca EA. Clinical decision support systems: Perspectives in dentistry. J Dent Educ 2004; 68(6): 589-97. 
9. Lee SJ, Lee S, Lim J, Ahn SJ, Kim TW. Cluster analysis of tooth size in subjects with normal occlusion. Am J Orthod 
Dentofacial Orthop 2007; 132(6): 796-800. 
10. Hwang HS, Youn IS, Lee KH, Lim HJ. Classification of facial asymmetry by cluster analysis. Am J Orthod 
Dentofacial Orthop 2007; 132(3): 279-6. 
11. de Veld DC, Skurichina M, Witjes MJ, Duin RP, Sterenborg DJ, Star WM, et al. Autofluorescence characteristics of 
healthy oral mucosa at different anatomical sites. Lasers Surg Med 2003; 32(5): 367-76. 
12. Saudi H. A periodontal expert system as an aid in periodontal treatment planning. Egypt Dent J 2002; 48: 1087. 
13. Shankarapillai R, Mathur K, Nair MA, Rai N, Mathur A. Periodontitis risk assessment using two artificial neural 
networks-a pilot study. International Journal of Dental Clinics 2010; 2(4): 36-40. 
14. Allahverdi N, Akcan T. A Fuzzy Expert System design for diagnosis of periodontal dental disease. Proceedings of the 
 
 
 
 
 
http://johoe.kmu.ac.ir,    7 October 
      194       J Oral Health Oral Epidemiol/ Autumn 2017; Vol. 6, No. 4 
Ehtesham et al. Use of the CDSS in OSCC diagnosis 
5
th
 International Conference on Application of Information and Communication Technologies (AICT); 2011 Oct  
12-14; Baku, Azerbaijan. 
15. Yagi M, Ohno H, Takada K. Decision-making system for orthodontic treatment planning based on direct 
implementation of expertise knowledge. Conf Proc IEEE Eng Med Biol Soc 2010; 2010: 2894-7. 
16. Pegon-Machat E, Decerle N, Tubert-Jeannin S. Development and evaluation of a triage tool for patients in a dental 
emergency unit. Sante Publique 2015; 27(1): 79-88. [In French]. 
17. Thanathornwong B, Suebnukarn S, Ouivirach K. Decision support system for predicting color change after tooth 
whitening. Comput Methods Programs Biomed 2016; 125: 88-93. 
18. Welch BM, Kawamoto K. Clinical decision support for genetically guided personalized medicine: a systematic review. 
J Am Med Inform Assoc 2013; 20(2): 388-400. 
19. Abernethy AP, Samsa GP, Matchar DB. A clinical decision and economic analysis model of cancer pain management. 
Am J Manag Care 2003; 9(10): 651-64. 
20. Finlayson SG, Levy M, Reddy S, Rubin DL. Toward rapid learning in cancer treatment selection: An analytical engine 
for practice-based clinical data. J Biomed Inform 2016; 60: 104-13. 
21. Mi H, Petitjean C, Dubray B, Vera P, Ruan S. Robust feature selection to predict tumor treatment outcome. Artif Intell 
Med 2015; 64(3): 195-204. 
22. Cakir A, Demirel B. A software tool for determination of breast cancer treatment methods using data mining approach. 
J Med Syst 2011; 35(6): 1503-11. 
23. Bury J, Hurt C, Roy A, Bradburn M, Cross S, Fox J, et al. A quantitative and qualitative evaluation of LISA, a decision 
support system for chemotherapy dosing in childhood acute lymphoblastic leukaemia. Stud Health Technol Inform 
2004; 107(Pt 1): 197-201. 
24. Gerbert B, Bronstone A, Maurer T, Hofmann R, Berger T. Decision support software to help primary care physicians 
triage skin cancer: A pilot study. Arch Dermatol 2000; 136(2): 187-92. 
25. Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS Trial: A cluster 
randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br 
J Cancer 2007; 97(4): 486-93. 
26. Ozanne EM, Howe R, Omer Z, Esserman LJ. Development of a personalized decision aid for breast cancer risk 
reduction and management. BMC Med Inform Decis Mak 2014; 14: 4. 
27. Javan Amoli AH, Maserat E, Safdari R, Zali MR. Electronic Risk Assessment System as an Appropriate Tool for the 
Prevention of Cancer: A Qualitative Study. Asian Pac J Cancer Prev 2015; 16(18): 8595-8. 
28. Shelton JB, Ochotorena L, Bennett C, Shekelle P, Kwan L, Skolarus T, et al. Reducing PSA-based prostate cancer 
screening in men aged 75 years and older with the use of highly specific computerized clinical decision support. J Gen 
Intern Med 2015; 30(8): 1133-9. 
29. Hills RL, Kulbok PA, Clark M. Evaluating a quality improvement program for cervical cancer screening at an urban 
safety net clinic. Health Promot Pract 2015; 16(5): 631-41. 
30. Maserat E, Seied Farajollah SS, Safdari R, Ghazisaeedi M, Aghdaei HA, Zali MR. Information engineering and 
workflow design in a clinical decision support system for colorectal cancer screening in Iran. Asian Pac J Cancer Prev 
2015; 16(15): 6605-8. 
31. Lundin J, Lundin M, Isola J, Joensuu H. Evaluation of a web-based system for survival estimation in breast cancer. 
Stud Health Technol Inform 2003; 95: 788-93. 
32. Sidiropoulos K, Glotsos D, Kostopoulos S, Ravazoula P, Kalatzis I, Cavouras D, et al. Real time decision support 
system for diagnosis of rare cancers, trained in parallel, on a graphics processing unit. Comput Biol Med 2012; 42(4): 
376-86. 
33. Exarchos KP, Goletsis Y, Fotiadis DI. A multiscale and multiparametric approach for modeling the progression of oral 
cancer. BMC Med Inform Decis Mak 2012; 12: 136. 
34. Nguyen AN, Lawley MJ, Hansen DP, Bowman RV, Clarke BE, Duhig EE, et al. Symbolic rule-based classification of 
lung cancer stages from free-text pathology reports. J Am Med Inform Assoc 2010; 17(4): 440-5. 
35. Nguyen AN, De J, Nguyen J, Padula A, Qu Z. A teaching database for diagnosis of hematologic neoplasms using 
immunophenotyping by flow cytometry. Arch Pathol Lab Med 2008; 132(5): 829-37. 
36. Righi LV. Oncotherapy: A system for requesting chemotherapy protocols. Stud Health Technol Inform 2015; 216: 1121. 
37. Yilmaz AA, Ozdemir L. Development and implementation of the clinical decision support system for patients with 
cancer and nurses' experiences regarding the system. Int J Nurs Knowl 2017; 28(1): 4-12. 
38. Abrantes D, Pimentel-Nunes P, Dinis-Ribeiro M, Coimbra M. Identifying technology interaction opportunities within a 
gastroenterology exam room. Stud Health Technol Inform 2015; 210: 652-6. 
39. Al-Kadi OS. A multiresolution clinical decision support system based on fractal model design for classification of 
histological brain tumours. Comput Med Imaging Graph 2015; 41: 67-79. 
40. Bountris P, Haritou M, Pouliakis A, Margari N, Kyrgiou M, Spathis A, et al. An intelligent clinical decision support 
 
 
 
 
 
http://johoe.kmu.ac.ir,    7 October 
       
J Oral Health Oral Epidemiol/ Autumn 2017; Vol. 6, No. 4       195 
Ehtesham et al. Use of the CDSS in OSCC diagnosis 
system for patient-specific predictions to improve cervical intraepithelial neoplasia detection. Biomed Res Int 2014; 
2014: 341483. 
41. Rasoolimoghadam M, Safdari R, Ghazisaeidi M, Maharanitehrani M, Tahmasebiyan S. Designing decision support 
system to detect drug interactions type 2 diabetes. Acta Inform Med 2015; 23(6): 336-8. 
42. Walker JG, Licqurish S, Chiang PP, Pirotta M, Emery JD. Cancer risk assessment tools in primary care: a systematic 
review of randomized controlled trials. Ann Fam Med 2015; 13(5): 480-9. 
43. Exarchos KP, Goletsis Y, Fotiadis DI. Multiparametric decision support system for the prediction of oral cancer 
reoccurrence. IEEE Trans Inf Technol Biomed 2012; 16(6): 1127-34. 
44. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer 
prognosis and prediction. Comput Struct Biotechnol J 2015; 13: 8-17. 
45. Ayer T, Alagoz O, Chhatwal J, Shavlik JW, Kahn CE, Jr., Burnside ES. Breast cancer risk estimation with artificial 
neural networks revisited: Discrimination and calibration. Cancer 2010; 116(14): 3310-21. 
46. Park K, Ali A, Kim D, An Y, Kim M, Shin H. Robust predictive model for evaluating breast cancer survivability. Eng 
Appl Artif Intell 2013; 26(9): 2194-205. 
47. Holt TA, Thorogood M, Griffiths F, Munday S, Friede T, Stables D. Automated electronic reminders to facilitate 
primary cardiovascular disease prevention: Randomised controlled trial. Br J Gen Pract 2010; 60(573): e137-e143. 
48. Gilutz H, Novack L, Shvartzman P, Zelingher J, Bonneh DY, Henkin Y, et al. Computerized community cholesterol 
control (4C): Meeting the challenge of secondary prevention. Isr Med Assoc J 2009; 11(1): 23-9. 
49. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100(1): 57-70. 
50. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144(5): 646-74. 
51. Pasini FS, Maistro S, Snitcovsky I, Barbeta LP, Rotea Mangone FR, Lehn CN, et al. Four-gene expression model 
predictive of lymph node metastases in oral squamous cell carcinoma. Acta Oncol 2012; 51(1): 77-85. 
52. Fang L, Sun L, Hu FF, Chen QE. Effects of FasL expression in oral squamous cell cancer. Asian Pac J Cancer Prev 
2013; 14(1): 281-5. 
53. Randhawa V, Acharya V. Integrated network analysis and logistic regression modeling identify stage-specific genes in 
Oral Squamous Cell Carcinoma. BMC Med Genomics 2015; 8: 39. 
54. Tang XH, Urvalek AM, Osei-Sarfo K, Zhang T, Scognamiglio T, Gudas LJ. Gene expression profiling signatures for 
the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology. 
Oncotarget 2015; 6(27): 24424-35. 
55. Jiang Q, Yu YC, Ding XJ, Luo Y, Ruan H. Bioinformatics analysis reveals significant genes and pathways to target for 
oral squamous cell carcinoma. Asian Pac J Cancer Prev 2014; 15(5): 2273-8. 
56. Liu Y, Liu CX, Wu ZT, Ge L, Zhou HM. Mining proteins associated with oral squamous cell carcinoma in complex 
networks. Asian Pac J Cancer Prev 2013; 14(8): 4621-5. 
57. Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: Avenues to early detection. Head Neck Oncol 
2011; 3: 33. 
58. Quaglini S, Sacchi L, Lanzola G, Viani N. Personalization and patient involvement in decision support systems: current 
trends. Yearb Med Inform 2015; 10(1): 106-18. 
59. Mertz E, Bolarinwa O, Wides C, Gregorich S, Simmons K, Vaderhobli R, et al. Provider attitudes toward the 
implementation of clinical decision support tools in dental practice. J Evid Based Dent Pract 2015; 15(4): 152-63. 
60. Meulendijk MC, Spruit MR, Willeboordse F, Numans ME, Brinkkemper S, Knol W, et al. Efficiency of clinical 
decision support systems improves with experience. J Med Syst 2016; 40(4): 76. 
61. Kesselheim AS, Cresswell K, Phansalkar S, Bates DW, Sheikh A. Clinical decision support systems could be modified 
to reduce 'alert fatigue' while still minimizing the risk of litigation. Health Aff (Millwood) 2011; 30(12): 2310-7. 
62. Mohammadzadeh N, Safdari R, Baraani A, Mohammadzadeh F. Intelligent data analysis: The best approach for 
chronic heart failure (CHF) follow up management. Acta Inform Med 2014; 22(4): 263-7. 
63. Safdari R, Kadivar M, Langarizadeh M, Nejad AF, Kermani F. Developing a Fuzzy Expert System to predict the 
risk of neonatal death. Acta Inform Med 2016; 24(1): 34-7. 
 
